Intravenous β-blockers in STEMI: what you are about to do,do it quickly

Ibanez B James S Agewall S , et al.; ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2018; 39: 119–177.

Martinez-Milla J Raposeiras-Roubin S Pascual-Figal DA , et al. Role of beta-blockers in cardiovascular disease in 2019. Rev Esp Cardiol (Engl Ed) 2019; 72: 844–852.

Freemantle N Cleland J Young P , et al. Beta blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 1999; 318: 1730–1737.

Chatterjee S Chaudhuri D Vedanthan R , et al. Early intravenous beta-blockers in patients with acute coronary syndrome – a meta-analysis of randomized trials. Int J Cardiol 2013; 168: 915–921.

Chen ZM Pan HC Chen YP , et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005; 366: 1622–1632.

Ibanez B Macaya C Sanchez-Brunete V , et al. Effect of early metoprolol on infarct size in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial. Circulation 2013; 128: 1495–1503.

Roolvink V Ibanez B Ottervanger JP , et al.; EARLY-BAMI Investigators. Early intravenous beta-blockers in patients with ST-segment elevation myocardial infarction before primary percutaneous coronary intervention. J Am Coll Cardiol 2016; 67: 2705–2715.

Er F Dahlem KM Nia AM , et al. Randomized control of sympathetic drive with continuous intravenous esmolol in patients with acute ST-segment elevation myocardial infarction: the BEtA-Blocker Therapy in Acute Myocardial Infarction (BEAT-AMI) trial. JACC Cardiovasc Interv 2016; 9: 231–240.

Hanada K Higuma T Nishizaki F , et al. Randomized study on the efficacy and safety of landiolol, an ultra-short-acting beta1-adrenergic blocker, in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Circulation J: official journal of the Japanese Circulation Society 2012; 76: 439–445.

Hoedemaker NP Roolvink V de Winter RJ , et al. Early intravenous beta-blockers in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a patient-pooled meta-analysis of randomized clinical trials. Eur Heart J Acute Cardiovasc Care 2020; 9(5).

Pizarro G Fernandez-Friera L Fuster V , et al. Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction). J Am Coll Cardiol 2014; 63: 2356–2362.

Roolvink V Hemradj VV Ottervanger JP , et al.; Zwolle Myocardial Infarction Study Group. Effects of chronic beta-blocker treatment on admission haemodynamics in STEMI patients treated with primary angioplasty. Eur Heart J Acute Cardiovasc Care 2020; 9(5).

Garcia-Ruiz JM Fernandez-Jimenez R Garcia-Alvarez A , et al. Impact of the timing of metoprolol administration during STEMI on infarct size and ventricular function. J Am Coll Cardiol 2016; 67: 2093–2104.

Garcia-Prieto J Villena-Gutierrez R Gomez M , et al. Neutrophil stunning by metoprolol reduces infarct size. Nat Commun 2017; 8: 14780.

Ibanez B Aletras AH Arai AE , et al. Cardiac MRI endpoints in myocardial infarction experimental and clinical trials: JACC Scientific Expert Panel. J Am Coll Cardiol 2019; 74: 238–256.

Lobo M Galan-Arriola C Rossello X , et al. Metoprolol blunts the time-dependent progression of infarct size. Basic Res Cardiol 2020; 115: 55.